This content is from the "Advancing the Science of Cancer in Latinos: 2024 Conference Proceedings."
Increasing Participation in Pediatric Cancer Clinical Trials
Dr. Paula Aristizabal is Associate Professor of Pediatrics in the Division of Pediatric Hematology and Oncology, Medical Director of the International Outreach Program, and Quality Improvement Lead at the University of California San Diego and Rady Children’s Hospital. Differences in pediatric cancer Dr. Aristizabal’s presentation covered the demographic shift in the US, differences in pediatric cancer, gaps in clinical trial participation in pediatric cancer research, challenges to clinical trial participation in Latinos, and strategies to improve recruitment of Latinos to clinical trials. The Latino population ...
This content is from the "Advancing the Science of Cancer in Latinos: 2024 Conference Proceedings."
Obesity and Cancer: What We Know Now About Individual and Other Factors
Dr. Monica C. Serra is Associate Professor and Research Health Scientist in the Department of Medicine, Division of Geriatrics, Gerontology & Palliative Medicine and the Sam and Ann Barshop Institute for Longevity and Aging Studies at University of Texas Health Science Center San Antonio (UTHSCSA). Obesity and cancer Dr. Serra began by discussing obesity and severe obesity, which have become more common in the US in recent years. In 2011, 27% of adults 18 years of age or older had obesity or severe obesity, and by 2020, 32% of adults 18 years of age or older had obesity or severe obesity. Furthermore, in ...
This content is from the "Advancing the Science of Cancer in Latinos: 2024 Conference Proceedings."
Inclusion in Action: Breaking Open the Leaky Pipeline to Create Pathways & Design Spaces that Improve Representation
Dr. Idalid “Ivy” Franco is works in the Department of Radiation Oncology at Brigham and Women’s Hospital and Dana-Farber Cancer Institute at Harvard Medical School. The effect of oppression on workforce incorporation Dr. Franco’s presentation began by looking at the context and long-standing hurdles to recruitment, retention, and professional success of a workforce that resembles the US population. This historical context started with American slavery, followed by years of segregation, laying a foundation of decades of judgement and mistreatment. This lies ...
This content is from the "Advancing the Science of Cancer in Latinos: 2024 Conference Proceedings."
Using Science to Address Latino Health Disparities Research
Eliseo J. Pérez-Stable, M.D., is Director of NIMHD at the National Institutes of Health (NIH). This plenary session occurred at 8:30 am., Wednesday, Feb. 21, 2024, at the 4th biennial Advancing the Science of Cancer in Latinos conference. Health differences Dr. Pérez-Stable began his presentation by discussing populations with health differences. While background along with social and economic factors are the fundamental pillars of health differences science, the intersection of these factors with rural populations, other overlooked groups, and people with physical or mental challenges are also important to ...
This content is from the "Advancing the Science of Cancer in Latinos: 2024 Conference Proceedings."
Designing Food Pantries to Improve Food Security Among Cancer Survivors
Dr. Sandi Pruitt is Associate Professor and Associate Director of Community Outreach, Engagement, and More in the Harold C. Simmons Comprehensive Cancer Center at the University of Texas Southwestern Medical Center. She also serves as Vice Chair of the Board of Directors for Crossroads Community Services. Food security and cancer Dr. Sandi Pruitt’s presentation discussed food security and cancer, best practices and solutions, and a Dallas pantry redesign. The gold standard for measuring food security is the validated US Food and Drug Administration (FDA) survey, which is offered in 6, 10, and 18 question ...
This content is from the "Advancing the Science of Cancer in Latinos: 2024 Conference Proceedings."
Residence in a Latino Enclave and Clinical Outcomes in Texas Children with Acute Lymphoblastic Leukemia
Dr. Jeremy Schraw is an Assistant Professor in the Division of Hematology-Oncology, Department of Pediatrics, at Baylor College of Medicine. Dr. Schraw began by pointing out the higher incidence of acute lymphoblastic leukemia (ALL) among Latino children, and the poorer overall survival (OS) following diagnosis. Non-medical drivers of health (NMDoH) likely contribute to these inconsistencies. In fact, children living in Latino enclaves, defined as neighborhoods with a high proportion of Latino residents, recent immigrants, and linguistically isolated households, have poorer OS after ...
This content is from the "Advancing the Science of Cancer in Latinos: 2024 Conference Proceedings."
Cancer Deaths Among Latinos in the COVID-19 Era: National and State Trends
Dr. Rogelio Sáenz is Professor of Sociology and Demography, Dean of the College of Public Policy, and holds the Mark G. Yudof Endowed Chair at the University of Texas at San Antonio. COVID-19 vulnerability Dr. Sáenz’s presentation began by discussing the vulnerability of people with cancer in the COVID-19 era. Over the last four years, a significant amount of research has observed the negative impact of COVID-19 on the survivability of people with cancer, along with rising numbers of cancer incidence and death due to disrupted health care. The growing Latino population is particularly vulnerable, ...
This content is from the "Advancing the Science of Cancer in Latinos: 2024 Conference Proceedings."
Task Force: Latino Researchers Against Cancer
This session occurred at 11:15 a.m., Friday, Feb. 23, 2024, at the 4th biennial Advancing the Science of Cancer in Latinos conference. Dr. Amelie Ramirez is Professor at the University of Texas (UT) San Antonio, Director of the Institute for Health Promotion Research, Chair of the Department of Population Health Sciences at UT Health San Antonio, and Associate Director of Cancer Outreach and Engagement at Mays Cancer Center. Dr. Ramirez’s presentation focused on communicating the mission and first year results of the Task Force: Latino Researchers Against Cancer (TFLRAC). The Task Force’s mission is to meet quarterly for 2 ...
This content is from the "Advancing the Science of Cancer in Latinos: 2024 Conference Proceedings."
Integrating Clinical and Genomic Data for Tumor Molecular Profiling in Latino Patients with Cancer
Dr. Enrique I. Velazquez-Villarreal is Assistant Professor in the Department of Integrative Translational Sciences at Beckman Research Institute and the City of Hope Comprehensive Cancer Center. Multi-omics and colorectal cancer in Latinos Dr. Velazquez-Villarreal’s presentation discussed how multi-omics can be used to understand colorectal cancer gaps in Latino individuals and how global and local ancestry impacts these disparities. He also described clinical and genomic data integration in colorectal cancer gaps and recent technologies used to understand the tumor microenvironment. ...
